Abstract
Molting is critical for the development and growth of insects. A central juncture in molting is the periodic and coordinated regulation of molting‐responsive mRNAs, which are essential for degrading the old cuticle and forming a new one. Knowledge is lacking of how molting‐responsive molecules function cooperatively and timely. Here, multi‐stage m6A modification levels, m6A reader condensation, and transcriptome analyses are developed to track the dynamic functional coupling for molting signals. The results showed that the molting‐responsive mRNAs are downregulated with the decrease of m6A modification levels from pre‐molt to the molt stage. The eIF3‐S6 is further identified, as an m6A reader, can directly bind to EcR A335 and Cht10 A7589. The low mRNA m6A modification in the molt stage facilitates eIF3‐S6 to undergo liquid–liquid phase separation (LLPS) by binding m6A‐containing EcR/Cht10 into condensed droplets for stabilizing the mRNAs. Disruption of m6A modification or breaking phase separation can cause a disorder of the new/old cuticle synthesis/degradation in molting. The disorder results in abnormal and unsuccessful molting, ultimately leading to the death of nymphs. Overall, the data mechanistically highlight an example of how two central machineries, m6A modification and LLPS, can accurately and functionally cooperate to optimize molting‐responsive gene expression for insect molting.
Keywords: liquid–liquid phase separation, locusts, m6A modification, molting
This research reveals that reduced m6A modifications during insect molting trigger liquid–liquid phase separation (LLPS) of the m6A reader eIF3‐S6, which binds and stabilizes key molting mRNAs, including EcR and Cht10. Disrupting m6A or LLPS causes cuticle remodeling defects and molting failure, highlighting the synergistic control of gene expression by m6A methylation and phase separation.

1. Introduction
The molting is critical for the development and growth of insects. The removal of superfluous and obsolete old cuticle and the remodeling of new cuticle are pivotal processes,[ 1 , 2 ] in which periodic and coordinated regulation of molting‐responsive mRNAs is essential for molting development.[ 3 ] Indeed, a significant proportion of molting‐responsive mRNAs was highest during intermolt and premolt stages and lowest at postmolt stage,[ 4 ] but several mRNAs are not necessary for molting development and even be harmful to molting at the late stage.[ 5 ] Therefore, a central but understudied question in molting is how molting‐responsive molecules function cooperatively and timely within a narrow time window during molting development.
The migratory locust Locusta migratoria, a worldwide pest species, undergoes five molting stages in its life cycle and has been widely used as a model for studying molting development.[ 6 ] Ecdysone signaling functions as a long‐range critical signal to generate temporal‐specific molting responses and coordinate the degeneration or remodeling processes during the locust molting.[ 7 , 8 ] Specifically, the active form of ecdysone, 20‐hydroxyecdysone (20E) binds to the heterodimeric nuclear hormone receptors, ecdysone receptor (EcR),[ 9 ] to transmit signals down, directly induces transcription of early 20E‐response genes such as BR‐C, E74A, and E75A.[ 7 ] Subsequently, these early genes further transduce and amplify the ecdysone signal to induce cell death by regulating a group of secondary‐response genes associated with both apoptosis and remodeling.[ 10 ] Indeed, several studies demonstrate that many secondary‐response genes, such as chitin synthase1, chitinase10, sinuous, Tweedle, Abd‐9, UDP‐N‐acetylglucosamine pyrophosphorylases, Chitin Deacetylase2, control the molting process, and knockdown of these molting‐responsive genes leads to a significant reduction in survival rate along with a molting defect of the locust.[ 5 , 11 , 12 , 13 , 14 ] However, these studies do not provide information on direct spatiotemporal regulation of transcriptional responses to drive the timely and precise expression of molting‐responsive genes and to ensure a delicate balance between the degradation and remodeling of the cuticle during insect molting.
RNA epigenetic modifications can reversibly fine‐tune transcriptional plasticity, providing the flexibility needed to orchestrate gene expression.[ 15 ] Among numerous RNA modifications, N 6‐methyladenosine (m6A), 5‐methylcytidine (m5C), N 7‐methylguanosine (m7G), and N 1‐methyladenosine (m1A) have been associated with cell proliferation, differentiation, invasion, migration, stemness, and metabolism.[ 16 , 17 , 18 , 19 , 20 , 21 ] N 6‐methyladenosine (m6A) is the most abundant type of modification in eukaryotic RNAs and plays important roles in multiple fundamental biological processes.[ 22 , 23 , 24 , 25 ] This modification is a reversible process regulated by “writers” (methyltransferases) and “erasers” (demethylases), responsible for positioning and removing the covalent chemical modifications, respectively,[ 26 , 27 ] and “readers”, downstream regulators that recognize and bind specific modifications.[ 28 ] Emerging evidence suggests that m6A methylation orchestrates the expression of a large number of developmentally regulated genes through controlling the balance by promoting or repressing the expression of the targeted locus in diverse programmed cell death processes.[ 29 , 30 ] Given that RNA‐mediated epigenetic regulation is a fundamental evolution strategy for orchestrating gene expression in a timely and reversible manner. We suspect whether this regulation impacts cuticle tissue removal/remodeling and how its alteration contributes to the balance between molting‐responsive transcripts degradation and stability in the normal molting development.
In this study, we explored the dynamic interplay between the transcription of molting‐responsive RNAs and m6A modification across the genome during the locust molting process. We simultaneously monitored both the transcription levels and m6A modification levels to understand their functional coupling. Our findings revealed that molting‐responsive RNAs were downregulated in concert with a decrease in mRNA m6A modification levels as locusts develop from the pre‐molt to the molt stage. We identified a crucial m6A reader in the integument that can bind to two molting‐responsive m6A‐modified mRNAs. Furthermore, we observed that m6A reader condensation coupling dynamically occurred during molting, facilitated by the incorporation of low m6A‐modified RNAs into granules. Collectively, these regulatory mechanisms enhance mRNA stability, and shed light on how central regulation machineries communicate and coordinate to optimize the expression of molting‐responsive genes for insect molting.
2. Results
2.1. The m6A Modification Dynamically Responds to Locusts Molting Process
Locusts undergo five molting stages from egg to adult, with each nymphal instar concluding with the molting process, which involves shedding and replacing their rigid exoskeleton (Figure 1A). To explore whether epigenetic modifications of RNA are associated with the molting process in locusts, we detected several prevalent modifications in organisms: m1A, m7G, m5C, and m6A. Employing qPCR assays, we first assessed the expression patterns of the enzymes responsible for adding (“writers”) and removing (“erasers”) these modifications during molting. The expression levels of m6A “writers” (Mettl3, Mettl14 and Wtap), and the putative “eraser” (Alkbh5), exhibited a similar wave‐like pattern, peaking at the early stage of the 4th or 5th instar (pre‐molt stage), and then dropping to their lowest level at the late stage of instar (molt stage). Conversely, the mRNA expression levels of m5C “writer” (N2un2), m1A “writer” (Trmt6 and Trmt61) and m7G “writer” (Mettl1 and Wdr4) exhibited a down‐regulated pattern from the early 4th instar to the early 5th instar nymph stage, which did not correlate with the molting process (Figure 1B), although the “eraser” Alkbh5, which was suggested as the potential demethylase by the homology alignment and structural analyses (Figure S1, Supporting Information), can remove m6A, m1A and m7G modifications,[ 31 , 32 ] showed a similar trend. Thus, we speculated that m6A modification is specifically associated with molting in locusts.
Figure 1.

The m6A modification dynamically responds to the locusts molting process. A) The locust undergoes five molting stages in its life cycle. Each nymph progresses through early‐stage, mid‐stage, late‐stage, and ends with molting to the early‐stage of the next instar nymph, thereby completing one instar cycle. B) Relative expression levels of the “writer” and “eraser” genes associated with m1A, m7G, m5C, and m6A RNA modifications. C, D) Total RNA m6A modification levels (C, n = 7) detected using colorimetry assays and the mRNA m6A modification levels (D, n = 8) detected using HPLC‐MS assays in the integuments of early‐stage, mid‐stage, and late‐stage of the 4th instar nymph and early‐stage of the 5th instar nymph. E) Effects of silencing Mettl3, Mettl14, Wtap, and Alkbh5 on locust mortality. The green arrow indicates the time for molting. F,G) Effects of silencing Mettl3 on the metabolism of new and old cuticle using Hematoxylin and eosin staining (F) and chitin staining (G). OC, old cuticle, NC, new cuticle. Different letters indicate statistically significant differences between groups using one‐way ANOVA (Tukey's multiple comparisons test, p < 0.05) (B–D). P values in survival curve were determined by the Kaplan–Meier statistical analysis (E). Data are presented as mean ± SEM.
We further employed a colorimetric ELISA‐like assay and high‐performance liquid chromatography tandem mass spectrometry (HPLC‐MS/MS) to measure the levels of m6A modifications in the integument of nymphs at various stages of each molting cycle, especially during the early, mid, and late stages of the 4th instar nymph, as well as the early‐stage of the 5th instar nymph. Both colorimetric and HPLC‐MS/MS assays indicated that the levels of m6A modifications in total RNA and mRNA levels mirrored the expression patterns of m6A writers and the eraser, peaking at the early stage, and progressively diminishing to their lowest levels by the late‐stage (Figure 1C,D; Figure S2A, Supporting Information). Thus, the RNA m6A modification exhibits dynamic fluctuations throughout the molting process in locusts.
To determine the role of m6A modification in the molting process, we conducted RNA interference (RNAi) experiments targeting Mettl3, Mettl14, Wtap, and Alkbh5, respectively, by microinjecting dsRNA three times at two‐day intervals into 4th instar nymphs. The transcript levels of these four genes were significantly reduced at 48 h post‐injection (Figure S2B, Supporting Information). Locusts injected with dsMettl3 displayed a distinct lethal phenotype caused by unsuccessful molting. Out of 65 fourth‐instar nymphs injected with dsMettl3, 48 (73.8%) failed to develop into the 5th instar nymphs and ultimately died during the molting stage, compared to only 5% mortality in the control group (Figure 1E). By contrast, after injection of dsMettl14, dsWtap, and dsAlkbh5, the mortality rates were only 35.2%, 12.7% and 31.7%, respectively, compared to the control rates of 5.5%, 5.5%, and 3.6% during the molting process (Figure 1E).
Given that the pronounced effects of dsMettl3 on molting compared to dsMettl14, dsWtap, and dsAlkbh5, subsequent experiments concentrated on Mettl3 to investigate the role of m6A modification in locust molting. To determine the cause of molting‐related mortality following Mettl3 RNAi knockdown, we first measured m6A level in the integuments of locusts using dot blot assays with m6A specific antibody. The results indicated that knockdown of Mettl3 decreased the m6A levels in total RNA by ≈83% (t = 3.482, p < 0.05, Figure S2C, Supporting Information). In contrast, knockdown of Mettl14 did not significantly change the m6A level (t = 0.2499, p > 0.05, Figure S2D, Supporting Information). We then determined the effects on cuticle formation following Mettl3 knockdown. Histological sections of the integuments of dsGFP‐ and dsMettl3‐injected nymphs from day 4 to day 7 were prepared for H&E and chitin staining. Both H&E and chitin staining indicated that the progresses of apolysis, new cuticle synthesis, and old cuticle degradation were delayed or impaired in nymphs injected with dsMettl3, compared to dsGFP control. Notably, at day 4 of 4th instar nymphs (N4D4), apolysis was delayed in dsMettl3 treated nymphs. By day 5 (N4D5), new cuticle formation was initiated in the control group, but was absent in dsMettl3‐injected locusts. By day 6(N4D6), the new multi‐lamellar cuticle was synthesized normally in the control group, yet was still absent in dsMettl3‐injected locusts. Finally, by day 7 (N4D7), the old cuticle was significantly degraded in control insects, whereas dsMettl3‐injected insects retained a thick, lamellar old cuticle structure. Altogether, nymphs injected with dsMettl3 failed to molt on time and remained in the nymph stage until death. These findings imply a critical role for m6A modification in the molting process (Figure 1F,G).
2.2. EcR and Cht10 m6A Modifications are Dynamic and Associated with Molting
To further explore the relationship between m6A RNA modification and molting, we first generated a comprehensive m6A profile across the transcriptome by employing methylated RNA immunoprecipitation sequencing (MeRIP‐seq) in the integument of nymphs at different developmental stages: early, mid, late 4th instar, and early 5th instar. We identified a comparable number of transcripts marked by m6A peaks in the early and mid 4th instar and early 5th instar nymphs, contrasting with a notably lower count of m6A transcripts in the late 4th instar nymphs (one‐way ANOVA, F = 96.44, p <0.0001; Figure 2B; Figure S3A, Supporting Information). We observed a significant enrichment of m6A peaks for the conserved RRACH motif (R is A/G and H is A/C/U) within the MeRIP group (Figure 2C; Figure S3D, Supporting Information). When examining the distribution of m6A across different stages, we found a preference for m6A peaks to occur within coding sequence (CDS) regions and 3′ untranslated region (3′ UTR), accounting for ≈50% and 45% of the confidently detected m6A peaks, respectively (Figure 2D). Given that CDS and UTR segments vary in length, we conducted an unbiased enrichment analysis by normalizing to the typical sizes of each segment. The stop codon region emerged as the segment most enriched with m6A across all samples (Figure 2E).
Figure 2.

EcR and Cht10 m6A modifications are dynamic and associated with molting. A) Schematic of MeRIP‐seq and RNA‐seq analysis. B) The number of m6A‐modified genes identified in the integuments of early‐stage, mid‐stage, and late‐stage of the 4th instar nymph and early‐stage of the 5th instar nymph by MeRIP‐seq analysis. C) Representative sequence motif identified from the m6A peaks in the m6A IP group. D) Pie chart showing the distribution of m6A peaks across gene regions (CDS, 5′UTR, and 3′UTR) in the locust integuments from early‐stage, mid‐stage, and late‐stage of the 4th instar nymph and early‐stage of the 5th instar nymph. E) Metagene profiles depicting the distribution of m6A across the transcriptome of the locust integuments from early‐stage, mid‐stage, and late‐stage of the 4th instar nymph and early‐stage of the 5th instar nymph. F) The number of common and specific m6A‐containing genes identified through the combined analysis of two paired samples from MeRIP‐seq (early‐stage vs late‐stage) and RNA‐seq (dsMettl3 and dsGFP). G) Biological pathways enriched by Gene Ontology analysis for the identified common set of 353 m6A‐containing differentially expressed genes from the combined analysis of MeRIP‐seq and RNA‐seq. H) Quadrant diagram displaying genes with significant reductions in both m6A enrichment (late vs early stage, MeRIP‐seq) and transcript levels (dsMettl3‐ vs dsGFP‐injected nymphs, RNA‐seq). Red highlighted boxes indicate the top candidate targets, EcR and Cht10, showing > 3‐fold downregulation upon Mettl3 knockdown. The m6A levels and expression levels of EcR and Cht10 were verified by m6A‐IP‐qPCR (n = 6) and qPCR (n = 5) analysis in the inset dashed panel. P values were determined by a two‐tailed unpaired t‐test. Data are presented as mean ± SEM. ** p < 0.01, *** p < 0.001.
To investigate the specific m6A‐containing genes related to locust molting, we performed RNA‐seq on integuments of nymphs injected with dsMettl3 and dsGFP, respectively, and analyzed the differentially expressed genes (DEGs) (Figure 2A). We then compared m6A‐containing genes in two paired samples from MeRIP‐seq data (early‐stage vs late‐stage), observing an increasing m6A modification trend in transcripts that preferentially exhibited significantly differential expression between RNA‐seq samples (dsMettl3 and dsGFP) (Figure S3A–C, Supporting Information). Among these transcripts, 353 DEGs were found to be common between the two transcriptomes (Figure 2F).
To determine which biological pathways were enriched for the identified common 353 m6A‐bearing DEGs, we performed Gene Ontology (GO) analysis. The analysis revealed that several candidate target genes were predominantly enriched in pathways related to development, cell communication, and signaling pathways (Figure 2G). Notably, the most enriched top pathway was tissue development, which included 14 candidate target genes. Among these, the top two candidate target genes, ecdysone receptor (EcR) and chitinase 10 (Cht10), exhibited significantly reduced m6A enrichment at the late stage compared to the early stage, along with > 3‐fold decreased transcript levels in dsMettl3‐injected nymphs relative to dsGFP‐injected controls (Figure 2G,H; Figure S3C, Supporting Information). Additionally, several m6A regulatory components, including two readers (Hnrnp and eIF3‐S6), an eraser (Alkbh5), and rRNA methyltransferases (Mettl5 and Zcchc4), were also found to be m6A‐modified and showed similar reduction patterns in both m6A enrichment (late vs early stage) and transcript abundance (dsMettl3 vs dsGFP groups) (Figure S3C, Supporting Information). We further validated the m6A level of EcR and Cht10 using MeRIP‐qPCR and assessed their expression levels after knockdown of Mettl3 by qPCR. The results showed that EcR and Cht10 have higher m6A levels in the MeRIP integuments than in the IgG group (t = 4.766, p < 0.001 for EcR, t = 16.44, p < 0.001 for Cht10, Figure 2H). The expression levels of EcR and Cht10 were significantly down‐regulated when Mettl3 was knocked down in locusts (t = 4.490, p < 0.01 for EcR, t = 3.096, p < 0.01 for Cht10, Figure 2H). Ecdysone receptor (EcR), a member of the nuclear receptor family, is well known to meditate the signaling of the steroid hormone ecdysone in insects.[ 33 , 34 ] Chitinase, on the other hand, catalyzes the degradation of chitin in insects.[ 35 , 36 ] These promising results led us to investigate whether the dynamic changes in m6A levels of these two target genes at different stages of each instar nymphs were associated with molting events.
2.3. m6A Reader eIF3‐S6 Binds with EcR/Cht10 by Recognizing m6A Marks for Molting
To confirm whether EcR and Cht10 are regulated by m6A modification during molting, we first performed a comprehensive analysis combined their expression patterns and m6A modification levels across the molting process. We observed a significant correlation between a sharp fall in EcR and Cht10 expressions and a drop in their m6A modification levels during nymphs molting (Figure 3A,B).
Figure 3.

m6A reader eIF3‐S6 binds with EcR/Cht10 by recognizing m6A marks for molting. A) The expression levels of EcR and Cht10 were determined in the integuments from early‐, mid‐, and late‐stage of the 4th instar nymph and early‐stage of the 5th instar nymph by qPCR. B) m6A‐IP‐qPCR analysis of m6A level for EcR and Cht10 in the integuments from early‐, mid‐, and late‐stage of the 4th instar nymph and early‐stage of the 5th instar nymph. C,D) The effects of silencing EcR (C) and Cht10 (D) on the mortality and molting process of locusts. The green arrow indicates the time point for molting. E,F) The effects of silencing EcR (E) and Cht10 (F) on the metabolism of both new and old cuticles were assessed through Hematoxylin and eosin staining (E) and chitin staining (F). OC, old cuticle, NC, new cuticle. G,H) Relative expression levels of eIF3‐S6 in the integument of early‐, mid‐, and late‐stage of the 4th instar nymph and early‐stage of the 5th instar nymph by qPCR (G) and western blot (H). I) m6A‐IP‐qPCR analysis of m6A level for EcR and Cht10 after knockdown of Mettl3. J) RIP‐qPCR showing enrichment of EcR and Cht10 mRNA by the eIF3‐S6 antibody compared to IgG. K) The mRNA expression levels of EcR and Cht10 after knockdown of eIF3‐S6 in the locust integument. L) The effects of silencing eIF3‐S6 on the mortality and molting of locusts, with the green arrow indicating the time for molting. M,N) The effect of silencing eIF3‐S6 on the metabolism of new and old cuticle. Hematoxylin and eosin staining (M) and chitin staining (N) of the integument were determined in the locusts. Different letters indicate statistically significant differences between groups using one‐way ANOVA (Tukey's multiple comparisons test, p < 0.05) (A, B, G, and H). P values in survival curve were determined by the Kaplan–Meier statistical analysis (C, D, L). P values in MeRIP‐qPCR, RIP‐qPCR, and qPCR were determined by a two‐tailed unpaired t‐test (I, J, K). Data are presented as mean ± SEM. * p <0.05, ** p < 0.01, *** p < 0.001.
To verify the function of EcR and Cht10 in molting, we performed RNAi knockdown of EcR or Cht10 into locusts (Figure S5, Supporting Information). During molting, locusts injected with dsEcR or dsCht10 displayed a clear molting defect. Specially, all 60 nymphs injected with dsEcR, died (100%) during the molting process from the 4th to 5th instar, compared to only 4% (2 out of 50) of mortality in the control group (Figure 3C). Similarly, 75% of nymphs died after injection of dsCht10, relative to only 3.7% of mortality observed in the control group (Figure 3D).
We further examined the impact of EcR and Cht10 knockdown on integument structure using hematoxylin and eosin staining, as well as chitin staining (Figure 3E,F). Knockdown of EcR not only severely reduced chitin levels in the newly formed cuticle, reflecting impaired synthesis, but also prevented chitin degradation in the old cuticle. In contrast, Cht10 knockdown inhibited the degradation of old cuticle, the chitin of which was not diminished compared with that of the controls (Figure 3E,F). Thus, EcR and Cht10 are integral to the molting process in locusts, mediating the metabolism of both new and old cuticles.
To explore the relationship between m6A and ecdysone signaling target genes, we identified six reader genes in the locust genome, including YTH homologs (Ythdc1 and Ythdf2), eIF3 homolog (eIF3‐S6), HNRNP homologs (Hnrnp and Hnrnpc) and IGF2BP homolog (Igf2bp3) (Figure 3G; Figure S4, Supporting Information). We then analyzed the expression patterns of these readers in relation to EcR and Cht10. Notably, only eIF3‐S6 showed a similar dynamic wave‐like pattern to EcR and Cht10, with peak expression at the early instar and bottom levels at the late instar at both mRNA and protein levels (Figure 3A,G,H). In contrast, the other 5 readers exhibited inconsistent patterns to EcR and Cht10 (Figure 3A; Figure S4, Supporting Information). The results imply a potential binding relationship between the reader eIF3‐S6 and the molting targeting genes EcR and Cht10.
To determine whether eIF3‐S6 binds to EcR and Cht10 by recognizing m6A marks on mRNAs, we measured m6A levels of EcR and Cht10 after Mettl3 knockdown by MeRIP qPCR. The m6A level of EcR and Cht10 significantly decreased in the locusts that underwent Mettl3 knockdown, compared to locusts that received dsGFP injection (t = 3.168, p < 0.05 for EcR; t = 4.261, p < 0.01 for Cht10; Figure 3I). Additionally, we performed an RNA immunoprecipitation (RIP) assay using an antibody against the eIF3‐S6 protein in locust integument (Figure 3J). Both EcR and Cht10 were significantly enriched in the eIF3‐S6‐immunoprecipitated RNAs compared to those from IgG controls (t = 2.647, p < 0.05 for EcR; t = 6.986, p < 0.0001 for Cht10; Figure 3J). Thus, eIF3‐S6 can directly bind to m6A marks of EcR and Cht10 in the locust integument.
To determine the effects of eIF3‐S6 on its target genes EcR and Cht10 in molting, we quantified mRNA expression levels of EcR and Cht10 after the knockdown of eIF3‐S6 in locust integument (Figure 3K; Figure S5, Supporting Information). Injection of dseIF3‐S6 led to significant decreases in EcR and Cht10 mRNA levels compared to those in control locusts (t = 2.469, p < 0.05 for EcR; t = 3.029, p < 0.01 for Cht10; Figure 3K). To determine whether knockdown of eIF3‐S6 causes abnormal molting, we injected dsRNA targeting eIF3‐S6 into locusts. The nymphs displayed EcR‐ and Cht10‐like molting defects (Figure 3L), with 98.4% mortality from molting arrest. Abnormal individuals retained old cuticle fragments on legs, resulting from impaired chitin degradation that caused old cuticular thickening and mechanical shedding obstruction (Figure 3L–N).
2.4. eIF3‐S6 Binds with EcR/Cht10 by Recognizing EcR A335 and Cht10 A7589
We aimed to point the exact locations of m6A sites by employing GLORI (Global locating of RNA m6A at single‐nucleotide resolution) sequencing to map the m6A sites in EcR and Cht10 following knockdown of Mettl3. This approach revealed four potential methylation sites in EcR (A335, A1354, A1389, and A1412) and four sites in Cht10 (A1923, A7354, A7545, and A7589) (Figure 4A,B,E). To verify the reliability of these m6A sites, we generated EcR mutants (EcR A335C, A1354C, A1389C, A1412C and a quadruple mutant, Figure S6, Supporting Information) and Cht10 mutants (Cht10 A1923C, A7354C, A7545C, A7589C or a quadruple mutant, Figure S6, Supporting Information) to analyze their effects on m6A level (Figure 4C,F) and eIF3‐S6 binding capacity (Figure 4D,G). The MeRIP‐qPCR data showed that EcR mutants A1354C, A1389C, and A1412C as well as Cht10 mutants A1923C, A7354C, and A7545C, were robustly enriched by an m6A‐specific antibody, compared to the control IgG antibody. In contrast, enrichment was absent in both EcR (A335C and quadruple) and Cht10 (A7589C and quadruple) mutants (Figure 4C,F). This suggests that m6A modification was repressed in these mutants due to the mutation at EcR A335 site and Cht10 A7589 sites, rather than the mutations at EcR A1354C, A1389C, A1412C as well as Cht10 A1923C, A7354C, A7545C sites. Thus, EcR A335 and Cht10 A7589 are indeed m6A‐modified sites.
Figure 4.

eIF3‐S6 binds with EcR/Cht10 by recognizing EcR A335 and Cht10 A7589. A) The distribution of m6A sites across the transcriptome from the schematic of MeRIP‐seq and GLORI‐seq analysis. B) The four sites (A335, A1354, A1389, and A1412) of EcR were identified as potential methylation sites. C) The four m6A sites (A335, A1354, A1389, and A1412) of EcR were verified using EcR mutants (EcR A335C, A1354C, A1389C, A1412C, and a quadruple mutant) or EcR WT transfection into S2 cells by m6A‐IP‐qPCR assays. D) eIF3‐S6 exhibited strong binding affinity with the EcR A335 site by eIF3‐S6 RIP‐qPCR when transfection of EcR WT and EcR mutants into S2 cells. E) The four sites (A1923, A7354, A7545, and A7589) of Cht10 were identified as potential methylation sites. F) The four m6A sites (A1923, A7354, A7545, and A7589) of Cht10 were verified using Cht10 mutants (Cht10 A1923C, A7354C, A7545C, A7589C or a quadruple mutant) or Cht10 WT transfection into S2 cell by m6A‐IP‐qPCR assays. G) eIF3‐S6 exhibited strong binding affinity with Cht10 A7589 site by eIF3‐S6 RIP‐qPCR when transfection of Cht10 WT and Cht10 mutants into S2 cells. P values in MeRIP‐qPCR and RIP‐qPCR were determined by a two‐tailed unpaired t‐test (C, D, F and G). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant.
Furthermore, we examined eIF3‐S6 binding affinity to transfected cellular wild‐type and mutant RNAs. The eIF3‐S6 RIP experiment showed that EcR A335C mutant and EcR quadruple mutant as well as Cht10 A7589C and Cht10 quadruple mutant, exhibited diminished eIF3‐S6 binding to mutant RNA compared to wild‐type RNA (Figure 4D,G). These results indicate that mutagenesis of the m6A‐modified sites diminished eIF3‐S6 recognition and that eIF3‐S6 bound to EcR and Cht10 by recognizing the EcR A335 and Cht10 A7589 sites.
2.5. eIF3‐S6 Undergoes Phase Separation in Molting
To understand the impact of m6A on the expression of molting‐related genes EcR and Cht10, we investigated the biochemical properties of m6A‐binding protein eIF3‐S6. This protein comprises an 11 kDa eIF3_N domain for m6A binding, and a 42 kDa low‐complexity domain with prion‐like domains based on computational Prion‐Like Amino Acid Composition (PLAAC) analysis (Figure 5A; Figure S7A, Supporting Information). We hypothesized that low‐complexity sequences might form liquid droplets due to phase separation, as previously reported (5,6). To test this hypothesis, we purified full‐length eIF3‐S6 from locusts (Figure S7B, Supporting Information), and observed the formation of spherical droplets that underwent time‐dependent coalescence from small to large sizes under phase contrast microscopy (Figure 5B). Following photobleaching (FRAP), eIF3‐S6 droplets showed dynamic fluorescence recovery, reaching near‐initial signal intensity within ≈150 s (Figure 5C). The formation of eIF3‐S6 droplets was enhanced by NaAsO2 and dampened by 1, 6‐Hexanediol, a phase separation inhibitor (Figure 5D). Overall, these data indicated that eIF3‐S6 exhibits characteristics of liquid‐liquid phase separation (LLPS) in vitro.
Figure 5.

eIF3‐S6 undergoes phase separation in molting. A) The prion‐like domain disorder sequence was generated using the PLAAC (Prion‐like amino acid composition) tool. The low complexity domain is a ≈42 kDa region. The ≈11 kDa eIF3‐N domain shows binding affinity to m6A. B) Phase separation assays in vitro were performed to detect the formation of eIF3‐S6 droplets. The small droplets of purified recombinant eIF3‐S6 underwent fusion to form larger ones over time. C) Fluorescence recovery after photo‐bleaching (FRAP) assays were used to detect the fluorescence recovery of eIF3‐S6 droplets. The changes in the fluorescence intensity of the droplets post‐photobleaching were plotted over time, with the curve representing the mean fluorescence intensity across distinct droplets (n = 4). D) The phase separation of eIF3‐S6 was enhanced by increasing of salt (NaCl) and inhibited by 1, 6‐Hexanediol. E) The procedure of b‐isox precipitation and mass spectrometry analysis. F) The integuments lysate from the molt stage was subjected to precipitation by b‐isox. Coomassie brilliant blue staining of an SDS‐polyacrylamide gel in total, supernatant, and b‐isox precipitation samples, as analyzed by western blotting. Size markers are labeled left of the gel. G) Ten proteins were identified from mass spectrometry analysis on b‐isox precipitation of integuments from the late stage of the 4th instar nymphs. H) Relative protein levels (n = 3) of both eIF3‐S6 and G3BP1 in b‐isox supernatant and precipitation from integuments of the late stage of the 4th instar nymphs. I) eIF3‐S6 and G3BP1 colocalized within the same condensed droplets in the integument cells of locusts through an immunohistochemistry assay. J) The interaction between eIF3‐S6 and G3BP1 in locust integuments was confirmed by co‐immunoprecipitation assays. K) The distribution of eIF3‐S6 condensation droplets in the primary cells of the locust integument after the injection of 1, 6‐Hexanediol by immunohistochemistry assays, injection of PBS is used as the control. L–N) The expression levels of eIF3‐S6 (L for mRNA level, M for protein level) and EcR/Cht10 (N) were assessed in the locust integuments after the injection of 1, 6‐Hexanediol by qPCR and western blot. O) The effects of 1, 6‐Hexanediol on locust mortality were analyzed after injection. The molting phenotype showed that the nymphs injected with 1, 6‐Hexanediol exhibited abnormal molting. P values were determined by a two‐tailed unpaired t‐test (L, M, and N). P values in survival curve were determined by the Kaplan–Meier statistical analysis (O). Data are presented as mean ± SEM. * p <0.05, *** p < 0.001.
To confirm whether phase separation occurs during molting, we identified potential phase‐separation proteins in the integument of molting locusts using b‐isox precipitations (Figure 5E). Mass spectrometry analysis of b‐isox precipitates identified 10 proteins (Figure 5F), including eIF3‐S6, which showed significantly enriched (p < 0.001, fold change = 15.3, Figure 5G). Other proteins known to trigger and undergo LLPS, such as G3BP1, Ythdf2, and Ythdc1,[ 37 , 38 , 39 ] were also enriched (Figure 5G), implying an important role for phase separation in molting. To confirm whether Ythdf2 and Ythdc1, as the m6A readers,[ 28 , 40 ] were responsible for the molting, we monitored locusts molting after dsYthdf2 and dsYthdc1 injection, respectively (Figure S8A,C, Supporting Information). The nymphs molted normally, with mortality rates of 12.7% for dsYthdf2 and 8.8% for dsYthdc1, compared to 3.6% for dsGFP‐injected controls (Figure S8B,D, Supporting Information). We furtherly investigated whether eIF3‐S6 undergoes phase separation to form condensates in the locust integument in molting. G3BP1, which acts as a molecular marker of ribonucleoprotein (RNP) granule and can trigger RNA‐dependent LLPS.[ 39 ] We next examined whether eIF3‐S6 and G3BP1 colocalize in locust integuments. As expected, both eIF3‐S6 and G3BP1 were observed in the same condensed cytoplasmic droplets within integument cells (Figure 5H,I). Furthermore, co‐immunoprecipitation assays confirmed a direct interaction between eIF3‐S6 and G3BP1 in locust integuments (Figure 5J). Thus, the direct interaction between eIF3‐S6 and G3BP1 in cytoplasmic condensates was mediated through LLPS.
To further verify the function of LLPS in molting, we injected 1, 6‐Hexanediol, into locusts at the pre‐molt stage and observed a significant reduction of eIF3‐S6 condensation droplets in the integument (Figure 5K). Since eIF3‐S6 can bind EcR and Cht10 through recognizing m6A marks, we assessed their expression levels after injection of 1, 6‐Hexanediol, and found a significant decrease (t = 8.334, p < 0.0001 for eIF3‐S6 mRNA level; t = 6.263, p < 0.05 for eIF3‐S6 protein level; t = 2.269, p < 0.05 for EcR; t = 2.932, p < 0.05 for Cht10) (Figure 5L–N). These results suggest that eIF3‐S6 undergoes LLPS by binding with EcR and Cht10 during molting.
Locusts treated with 1,6‐hexanediol exhibited significantly higher rates of molting abnormalities and mortality (37.5%) compared to controls (3.7%) (Figure 5O). Therefore, the phase separation‐mediated by eIF3‐S6 condensates with EcR and Cht10 plays a critical role in regulating molting.
2.6. eIF3‐S6 Binds with m6A‐EcR/Cht10 to form Droplet Granules for Protecting the Target mRNAs Stability
To examine the role of eIF3‐S6 in molting through phase separation dynamics, we isolated integument primary cells and compared eIF3‐S6 condensates in early (pre‐molt stage) and late instars (molt stage). The results showed that eIF3‐S6 formed fusion condensates with intense signals in late‐ but not early‐instar integument cells (Figure 6A), indicating molting‐stage‐specific phase separation is required for normal molting.
Figure 6.

eIF3‐S6 binds with m6A‐EcR/Cht10 to form droplet granules for protecting the target mRNAs stability. A) eIF3‐S6 formed spherical condensates that displayed a strong fusion signal in the primary integument cells of the late instar, but markedly diminished in those of the early instar by immunohistochemistry assay. B) m6A‐IP‐qPCR analysis of m6A level for EcR and Cht10 in both early instar and late instar of locusts after b‐isox precipitation. C) The expression levels of EcR and Cht10 were evaluated in both early instar and late instar by qPCR after b‐isox precipitation. D,E) The total RNA m6A levels in the b‐isox precipitation or supernatant of the dseIF3‐S6‐injected locusts. The dsGFP‐injected locusts served as controls (D), and dot blot bands were quantified using densitometry (E). F) The mRNA expression levels of EcR and Cht10 in the b‐isox precipitation of the dseIF3‐S6 and dsGFP‐injected locusts by qPCR. G) The b‐isox precipitation‐qPCR analysis of expression levels for EcR and Cht10 in the condensate droplets of the locust integuments after RNAi Mettl3. H) The distribution of eIF3‐S6 condensation droplets in the locust integument following eIF3‐S6‐knockdown by immunohistochemistry assays. I) The procedure of RNA stability assay. J) The half‐lives of EcR and Cht10 mRNA in the primary cells of locusts at the late instar following eIF3‐S6‐knockdown. P values were determined by a two‐tailed unpaired t‐test (B, C, E and F). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.
Given our findings that eIF3‐S6 recognizes and binds m6A marks on both EcR and Cht10 in locust integuments, we next asked whether these m6A‐marked transcripts were specifically recruited into eIF3‐S6 condensates at the critical late instar period. We employed b‐isox precipitation analysis and anti‐m6A IP‐qPCR (MeRIP‐qPCR) to compare m6A levels of EcR and Cht10 transcripts across early and late instars. The results showed that significantly higher m6A enrichment of both transcripts in late‐instar condensates compared to early‐instar counterparts (t = 3.038, p < 0.05 for EcR, t = 14.25, p < 0.0001 for Cht10, Figure 6B). Consistently, b‐isox precipitation followed by qPCR analysis revealed significantly higher expression levels of both EcR and Cht10 transcripts in late‐instar condensates than those in early‐instar condensates (t = 2.644, p < 0.05 for EcR, t = 4.815, p < 0.0001 for Cht10, Figure 6C). Thus, the interaction between eIF3‐S6 and m6A‐modified EcR/Cht10 transcripts drives phase separation within biomolecular condensates during locust molting.
To confirm the functional interdependence between eIF3‐S6 and m6A‐modified EcR/Cht10 transcripts in condensates, we performed eIF3‐S6 knockdown in late‐instar locusts and measured m6A levels in condensate‐enriched mRNA. The m6A levels revealed a 77% reduction in condensate‐associated RNAs (b‐isox precipitation) from dseIF3‐S6‐injected locusts compared to dsGFP controls (t = 6.498, p < 0.01). In contrast, m6A levels in the non‐condensate fraction (b‐isox supernatant) showed no significant difference between dseIF3‐S6 and dsGFP groups (t = 6.303, p = 0.0032). (Figure 6D,E). Furthermore, mRNA levels of EcR and Cht10 in b‐isox‐isolated condensates were significantly reduced by 47% (t = 3.507, p < 0.01) and 72% (t = 10.46, p < 0.001), respectively, in dseIF3‐S6‐injected locusts compared to dsGFP controls (Figure 6F). Consistently, RNAi knockdown of Mettl3 in locusts significantly increases EcR and Cht10 expression levels within these granules (Figure 6G), revealing a critical link between m6A modification and phase separation. Immunofluorescence analysis revealed a marked decrease in eIF3‐S6‐positive condensates in the integument following eIF3‐S6 knockdown (Figure 6H). RNA stability assays revealed that the half‐lives of EcR and Cht10 mRNAs were significantly reduced in primary integument cells from eIF3‐S6‐knockdown locusts at the late‐instar (Figure 6I,J), demonstrating that eIF3‐S6‐containing condensates stabilize these transcripts during molting. All together, these data indicated that eIF3‐S6 binds to m6A‐EcR/Cht10 in a mutually dependent manner to form condensates that protect target mRNA stability.
2.7. Disturbance of m6A Modifications Leads to Decreased Phase Separation and Molting Failure
During the molting stage, the minimal levels of m6A modification on mRNAs coincided with eIF3‐S6 phase separation. We suspect that disturbing m6A levels could influence LLPS. To test this, we injected S‐adenosylmethionine (SAM), a universal methyl donor, into locusts at the mid‐instar stage, and we observed a significant increase in m6A levels of mRNAs in the late‐instar stage (t = 2.838, p < 0.05, Figure 7A). Moreover, SAM injection not only induced an elevated expression of EcR and Cht10 (t = 2.900, p < 0.05 for EcR; t = 2.606, p < 0.05 for Cht10; Figure 7B), but also promoted eIF3‐S6 levels in the integuments of locusts both at the mRNA (t = 4.814, p < 0.001; Figure 7C) and protein levels (t = 35.36, p < 0.001; Figure 7D).
Figure 7.

Decreased m6A modifications promote phase separation associated with the locust molting. A) The RNA m6A levels from locusts at the late‐stage of the 4th instar nymphs after the injection of S‐adenosylmethionine (SAM). Dot blot bands were quantified using densitometry. B) The expression levels of EcR and Cht10 in the late‐stage of the 4th instar nymphs after the injection of SAM by qPCR. C,D) The expression levels of eIF3‐S6 in the late‐stage of the 4th instar nymphs after the injection of SAM by qPCR (C) or western blot (D). E) The distribution of eIF3‐S6 condensation droplets in the locust integument following SAM injection or PBS injection (as the control) by immunohistochemistry assays. F) The effects of SAM on locust mortality. P values were determined by a two‐tailed unpaired t‐test (A–D). P values in survival curve were determined by the Kaplan–Meier statistical analysis (F). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Upon examining eIF3‐S6 localization in the integument after SAM injection, we observed that eIF3‐S6 remained diffusely cytoplasmic and failed to form distinct granule droplets. In contrast, PBS‐injected controls (with low m6A levels) exhibited clear droplet‐like eIF3‐S6 granules (Figure 7E). Thus, eIF3‐S6 granule formation depends on the maintenance of low m6A levels during molting.
To determine whether the loss of droplet granules in SAM‐injected locusts affects molting, we monitored nymphs until the molt stage. These individuals exhibited abnormal molting and failed to complete ecdysis, resulting in a 54% mortality rate (Figure 7F). Our findings demonstrate that m6A‐dependent regulation in the integument is essential for orchestrating phase separation during locust molting.
3. Discussion
Insect molting serves as a model for understanding how multi‐regulatory mechanisms coordinate to ensure the precise temporal expression of molting‐responsive genes during tissue degradation and remodeling. Here, we investigated the dynamic interplay between molting‐responsive RNA transcription, m6A modification levels, and m6A reader phase separation in response to molting signals. Our findings demonstrate that during the pre‐molt stage, m6A modification dynamically coordinates the temporal expression of molting‐responsive genes. As molting progresses, decreasing m6A levels trigger the degradation of key molting regulators EcR and Cht10. eIF3‐S6 binds to m6A‐modified EcR and Cht10 transcripts, forming LLPS condensates that protect these low‐m6A mRNAs from excessive degradation, thereby ensuring successful molting. Disruption of either condensate components or m6A modification abolishes phase separation, leading to molting defects (Figure 8 ). This work reveals an essential coupling mechanism between m6A modification and LLPS for mRNA stabilization during insect molting.
Figure 8.

Model of a mechanism for m6A modification‐instructed LLPS as a key driver in locusts molting. eIF3‐S6, as a key m6A reader in integument, recruits two key m6A‐modified EcR and Cht10 to undergo dynamic phase separation, thus promoting EcR and Cht10 mRNA stability for normal molting. In the pre‐molt stage, m6A modification of molting‐responsive genes coordinates their expression in a timely and dynamic fashion. However, in the molt stage, the molting‐responsive EcR and Cht10 undergo degradation with the decrease of their m6A levels. Consequently, the eIF3‐S6 binding with EcR A335 /Cht10 A7589 forms condensation droplets, which protect EcR and Cht10 from excessive degradation, thereby ensuring normal molting. Knockdown of each droplet member or disruption of m6A levels leads to the absent of phase separation, leading to abnormal molting.
RNA epigenetic modifications, particularly m6A, dynamically coordinate the expression of molting‐responsive genes in a timely manner during locust development. Disruption of the m6A pathway results in aberrant molting, ultimately leading to nymphal death. A recent study also demonstrated that the m6A pathway is essential for eclosion of T. castaneum.[ 41 ] Knockdown of m6A writers prevents shedding of the pupal cuticle; however, the specific role of m6A in regulating the ecdysis process of pupal remains unclear. In Drosophila, ≈40% of embryos cannot reach the larval stage when maternal Mettl3 and Mettl14 were simultaneously removed.[ 42 ] Similarly, m6A impacts caste differentiation and larval development of Apis mellifera.[ 43 ] Mettl3 and Mettl14‐mediated m6A modification suppresses juvenile hormone degradation of Plutella xylostella to minimize fitness costs in response to a pathogenic attack.[ 44 ] Collectively, m6A modifications are believed to play a crucial and evolutionarily conserved role in insect development.
Our results also highlight the key linkage between ecdysone signaling and the m6A machinery. Ecdysone signaling, a central regulator of molting (Figures S10A and S12A, Supporting Information), modulates the expression of RNA methylation enzymes. Injection of 20E can activate Mettl3 but repress Alkbh5 expression levels (Figure S11B,E, Supporting Information), although it has no effect on Mettl14 and Wtap expression (Figure S11C,D, Supporting Information). Dual‐luciferase assays revealed that Mettl3 promoter drove significantly higher expression than the reference reporter (Figure S12A, Supporting Information). However, 20E treatment did not significantly enhance the transcriptional activity of the Mettl3 promoter in S2 cells (Figure S12B, Supporting Information). These results suggest that 20E regulates Mettl3 expression independently of its promoter activity, but via alternative mechanisms. Furthermore, Mettl3 knockdown suppressed the transcription of 20E nuclear receptors, early 20E‐response genes, and chitin metabolic genes in locust integuments, whereas SAM injection had the opposite effect, upregulating their expression (Figure S13B,C, Supporting Information). Thus, m6A modification may serve as an intermediate junction gate responsive to ecdysone signaling, coordinating the expression of molting effectors.
The m6A reader eIF3‐S6, as a molecular sensor, can induce the LLPS in response to low m6A modification levels. eIF3 is generally considered a translation initiation factors that stimulate both the recruitment of the initiator tRNA, Met‐tRNAi Met, and mRNA to the 40S ribosomal subunit and subsequent scanning of the mRNA for the AUG start codon.[ 45 ] And there are barely studies on its dual functionality as both an m6A reader and LLPS regulator. Our mass spectrometry analysis identified eIF3‐S6 as a novel m6A reader that binds with molting‐responsive RNAs and exhibits phase separation capability. Like other characterized m6A readers, all three YTHDF proteins (YTHDF1, YTHDF2, YTHDF3) share a C‐terminal YTH domain and an N‐terminal IDR, enabling them to undergo LLPS.[ 46 ] These findings reveal a novel m6A reader‐driven phase separation, underlying the alternative functions of eIF3.
Phase separation formation and m6A modification levels exhibit a pattern of mutual increase and decrease for mRNA stabilization. During molting, when m6A levels of EcR and Cht10 are at their lowest, the m6A reader eIF3‐S6 undergoes phase separation, forming liquid droplet granules that recruit low‐abundance m6A‐modified mRNAs. When pre‐molting and post‐molting stages, elevated m6A modifications coincide with phase separation dissolution and serve as a critical regulatory mechanism for fine‐tuning the expression of molting‐responsive transcripts. Similarly, phase separation is involved in the process of RNA modifications, while RNA modifications reciprocally provide a regulatory mechanism for LLPS.[ 47 , 48 , 49 , 50 ] In vitro evidence suggests that high RNA levels keep RNA‐binding proteins soluble, whereas low RNA levels promote aberrant protein aggregation, leading to the formation of pathological gel‐like condensates in cells.[ 51 ] Specifically, m6A‐modified mRNAs are actively recruited into various membraneless organelles through YTHDF proteins, enabling compartment‐specific regulation of mRNA stability and translation.[ 52 ] These findings collectively demonstrate that the dynamic interplay between m6A modifications and LLPS serves as a reversible regulatory switch that precisely modulates transcriptional plasticity.
In conclusion, our findings propose a novel model in which m6A modified EcR and Cht10 mRNAs instruct a phase‐switch of eIF3‐S6 granules, regulating mRNA stability during the molting process in locusts. This work underscores a functionally coupled regulation system and highlights the orchestrated dynamics of interconnected multi‐step processes governing the pre‐molt to molting transition.
4. Experimental Section
Insects
The migratory locusts used in this study were reared at the College of Life Sciences, Capital Normal University, Beijing, China. Nymphs were reared in large boxes (40 cm × 40 cm × 40 cm) under a 14:10 light/dark photo regime at 30 °C ± 2 °C and provided with fresh wheat seedlings as food.
RNA Extraction and Quantitative PCR
Total RNA was extracted from integuments using TRIzol reagent (Invitrogen). The concentration and purity of RNA were assessed with a Nanodrop ND‐1000 spectrophotometer to verify RNA integrity. cDNA was synthesized using the PrimeScriptTM RT Reagent Kit with gDNA Eraser (TaKaRa). mRNAs were subjected to qPCR by using the Real Master Mix Kit (Tiangen) on a LightCycler 480 instrument (Roche). The PCR data were analyzed by the 2−ΔΔCt method, and β‐actin was used as the endogenous control. The primers for qPCR are listed in Table S1 (Supporting Information).
RNA m6A Methylation Assay
The EpiQuik m6A RNA Methylation Quantification Kit (Epigentek) was used to assess the content of m6A in total RNA, as previously reported.[ 53 ] Briefly, 200 ng of sample RNA, in conjunction with the m6A standard, were loaded into designated wells using RNA high‐binding solution. Subsequently, specific capture and detection antibodies were used to capture and assess m6A levels. The colorimetric m6A levels were quantified by measuring the absorbance of each well at an optical density of 450 nm, and the results were calculated based on the standard curve.
LC‐MS/MS
LC‐MS/MS for determination of m6A/A ratio was performed as previously described.[ 54 ] PolyA+ RNA was extracted from integuments of locusts at the early‐stage, mid‐stage, late‐stage of the 4th instar and early‐stage of the 5th instar using NEBNext Poly(A) mRNA Magnetic Isolation Module (NEB). Single nucleosides were generated through treatment with nuclease P1 (Sigma) and alkaline phosphatase (Sigma), and then quantified using LC‐MS/MS. The ratio of nucleoside‐to‐base ion mass transitions was calculated based on the measured concentrations.
m6A Dot Blot
m6A dot blots were performed as previously described with slight modifications.[ 55 ] Total RNAs (2500 ng) were double‐diluted and spotted onto a nylon membrane (Invitrogen). The membrane was then UV cross–linked, blocked and incubated with anti‐m6A antibody (Abcam, 1:1250) overnight at 4 °C. Subsequently, horseradish peroxidase‐conjugated goat anti‐rabbit IgG (Easybio, 1: 5000) was added to the blots for 2 h at room temperature and the membrane was detected by an ECL Western Blot Kit (Invitrogen). The same 2500 ng RNAs were spotted on the membrane, stained with methylene blue (Macklin) for 15 min, rinsed in PBST, and imaged.
RNAi Assay
Double‐stranded RNAs (dsRNAs) of green fluorescent protein (GFP), Mettl3, Mettl14, Wtap, Alkbh5, Ythdc1, Ythdf2, eIF3‐S6, EcR, and Cht10 were synthesized using T7 RiboMAX Express RNAi System (Promega) in accordance with the manufacturer's protocol. The injection and sampling methods of locusts were carried out as described previously.[ 56 ] The 2‐day‐old fourth instar nymphs were injected with 5 µg of dsRNA into the second ventral segment of the abdomen. Control nymphs were injected with an equivalent amount of dsGFP–RNA. The effect of RNAi on relative mRNA expression levels 48 h after injection was investigated by qPCR. The nymphs that typically showed abnormal ecdysis were used for hematoxylin and eosin staining and chitin staining. The primers used for the synthesis of dsRNAs targeting GFP, Mettl3, Mettl14, Wtap, Alkbh5, Ythdc1, Ythdf2, eIF3‐S6, EcR, and Cht10 are listed in Table S1 (Supporting Information). The nucleotide sequences used for RNAi are listed in Table S2 (Supporting Information).
MeRIP‐seq
The methylated m6A RNA immunoprecipitation (MeRIP) was conducted following the protocol provided by using the m6A MeRIP kit protocol (Bersinbio). Briefly, total RNA was isolated and purified using the RNA Clean & Concentrator kit (Zymo). Then the RNA samples were incubated with 5 µL of anti‐m6A antibody (Abcam), or IgG (Bersinbio) that had been pre‐conjugated to protein G‐magnetic beads in 500 µL IP buffer at 4 °C for 2 h. The IP complex was treated with proteinase K at 55 °C for 30 min. Libraries were prepared using the NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (NEB) for both IP and input RNA, and sequenced on the Illumina HiSeq point series platform. Each time point was performed in three biological replicates. Six integuments were involved in one biological replicate.
Data Processing
The raw sequencing data were filtered, and the cleaned data were mapped to the locust genome utilizing STAR 2.7.10a software. The differential gene expression between samples was quantified at the gene level employing RSEM v1.3.1. The differential analysis of the count data was executed with the DESeq2 (R version for 4.2). The GO enrichment analysis was conducted by the GOseq R package, and gene length bias was corrected. The significance analysis was performed by Fisher's Exact Test.
RNA Immunoprecipitation (RIP) Assays
The RIP assay was performed using a Magna RIP Quad Kit (Millipore) in accordance with the manufacturer's instructions. Ten integuments were collected and homogenized in ice‐cold RIP lysis buffer. The homogenates were stored at −80 °C overnight. A total of 10 µg of anti‐eIF3‐S6 antibody (Genscript Biotech Corporation) or normal rabbit IgG (Millipore), which served as a negative control, was pre‐incubated with magnetic beads. The frozen homogenates were thawed and centrifuged, and the supernatant was incubated with the magnetic bead–antibody complex at 4 °C overnight. Concurrently, a 30 µL portion of the sample lysate was reserved as “input”. The immunoprecipitated RNAs were reverse‐transcribed into cDNA using SuperScript IV (Invitrogen). qPCR was performed to quantify the expression levels of EcR and Cht10. To normalize the relative expression levels, the supernatants of the RIP lysate (input) and the IgG controls were assayed for specificity of RNA‐protein interactions.
Protein Expression and Fluorescence Recovery after Photobleaching (FRAP)
The full‐length of eIF3‐S6 was cloned into the vector pET28a to generate the recombinant protein. The primers are presented in Table S1 (Supporting Information). The recombinant protein was expressed in Escherichia coli BL21 (DE3) within LB medium at 16 °C and purified using Ni‐NTA. Subsequently, the target protein was diluted to 10 µmol L−1 and dispensed into the 96‐well plate. 2 µL of Alexa Fluor 488 fluorescent dye (Invitrogen) was added to each protein sample. After thorough mixing, it was allowed to stand for 5 min to enable the protein to fully bind the dye. The culture plate was placed under a laser scanning confocal microscope, and the target area was irradiated with a laser beam to instantaneously photobleach the fluorescently labeled protein in the designated area. Thereafter, real‐time imaging and recording of the bleached area were conducted using a fluorescence microscope, and the real‐time recovery process of the protein in the target area after photobleaching was observed. A specific time interval was set to collect the fluorescence signal intensity and record the variations in fluorescence intensity. The fluorescence recovery rate was calculated by analyzing the variations in fluorescence signal intensity over time.
NaASO2 and 1,6‐Hexanediol Treatment
To test the effect of NaASO2 and 1,6‐Hexanediol on the phase separation of eIF3‐S6, NaASO2 (Sigma) (10 mg mL−1) or 1,6‐hexanediol (Sigma) (1 mol L−1) was gently added into the recombinant eIF3‐S6 premixed with Alexa Fluor 488 fluorescent dye in 96‐well plates. The fluorescent signal of the target protein was observed under the confocal microscope. The size and frequency of droplet condensates were quantified during LLPS by R and ggforce (Figure S9, Supporting Information).
B‐isox Precipitation and Mass Spectrometry
These assays were performed as previously described with slight modifications.[ 57 ] Briefly, eight integuments were homogenized in ice‐cold RIPA lysis buffer and incubated on ice for 10 min. The supernatant was then collected after centrifugation at 14,000 rpm for 10 min. 10% of the supernatant was reserved as input. Subsequently, the remaining lysate was supplemented with b‐isox (Sigma), incubated on ice for 20 min, and centrifuged at 14,000 rpm for 10 min at 4 °C to separate the supernatant and precipitate. The RNA and protein from both the supernatant and precipitate were extracted using Trizol as above.
For mass spectrometry, samples were run on a 10% SDS‐PAGE gel and subjected to Coomassie staining. Total bands were then cut for each sample and submitted to the BGI Genomics for analysis.
Lifespan Assay
After the injection of dsRNA for Mettl3, Mettl14, Wtap, Alkbh5, Ythdc1, and eIF3‐S6, the locusts were raised in cages and fed wheat seedlings. The number of dead insects was recorded daily, and the survival rate was calculated within eight days in one group. The control group was injected with GFP dsRNA.
The lifespan assay for the injection of 1,6‐hexanediol or SAM on locusts was performed as above. The 2‐day‐old fourth instar nymphs were injected with 1,6‐hexanediol (2 µL,1 mol L−1) or SAM (2 µL, 80 µmol L−1) in the second ventral segment of the abdomen and reared in cages for eight days, dead locusts were scored and counted every day. The control group was injected with PBS.
Immunohistochemistry
The colocalization of eIF3‐S6 and G3BP1 was detected in the integument using immunohistochemistry. The integument was fixed in 4% paraformaldehyde overnight. Paraffin‐embedded integument tissue slides (5 mm thick) were deparaffinized in xylene and rehydrated with an ethanol gradient. The samples were blocked with 5% (wt/vol) skimmed milk for 30 min at room temperature and then incubated with affinity‐purified rabbit antibodies against eIF3‐S6 (1: 500, Genscript Biotech Corporation) and G3BP1 (1: 1000, Abclone). An Alexa Fluor 488‐conjugated goat anti‐rabbit antibody (1: 500, Life Technologies) was used as the secondary antibody for eIF3‐S6 and G3BP1 staining. Fluorescence was detected using an LSM 780 confocal laser‐scanning microscope (Zeiss). Images for both positive staining and negative controls were captured under the same conditions. The specificity of the antibody against eIF3‐S6 or G3BP1 was evaluated (Figure S10, Supporting Information).
Co‐Immunoprecipitation (CO‐IP) and Western Blot Analysis
For the interaction assay of eIF3‐S6 and G3BP1 in locusts, CO‐IP was conducted using a Dynabeads Protein G Immunoprecipitation Kit (Invitrogen) in accordance with the manufacturer's guidelines. Initially, 5 µg of either rabbit anti‐eIF3‐S6 or rabbit anti‐G3BP1 antibody was conjugated to 50 µL Dynabeads Protein G (Novex) for 30 min at room temperature. Subsequently, 400 µL of total protein extracted from the integuments of locusts using RIPA lysis buffer was added to the mixture. ≈10% of the total protein was stored as input. Rabbit IgG (ABclone) served as a negative control. Following three times of washing with washing buffer, the antibody‐protein complex was dissociated from the beads using elution buffer for subsequent Western blot analysis with either rabbit anti‐G3BP1 or rabbit anti‐eIF3‐S6.
Total proteins for Western blot analysis were first extracted by using TRIzol reagent. The proteins were subjected to gel electrophoresis and then transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). The membranes were blocked with 5% skimmed milk at room temperature for 2 h, followed by incubation with primary antibody (rabbit anti‐eIF3‐S6, 1: 500; rabbit anti‐G3BP1, 1:2000) in PBST overnight at 4 °C. Goat anti‐rabbit IgG was used as secondary antibody (CWBIO, 1:5000). Protein bands were detected by SuperSignal West Femto (Thermo Fisher Scientific). The intensities of the Western blot signals were quantified using Image J.
mRNA Stability Assay
The integument tissues of the locust nymphs were immediately dissected and snipped in a culture dish supplemented with Schneider's Drosophila Medium (Gibco) to release the epidermal cells. The cell suspension was transferred to a cell culture bottle and cultured for 3 to 6 h at 30 °C. Subsequently, the integument cells were transferred to 6‐well plates and treated with 0.2 mm actinomycin D (G‐CLONE) for 0, 2, 4, 6, and 8 h. The samples were then collected for total RNA extraction and cDNA synthesis, which were performed according to the methods described above. qPCR was conducted to quantify mRNA levels.
GLORI‐seq
RNA protection, deamination, and deprotection were performed according to a method that was described previously.[ 58 ] Briefly, RNA fragments were generated through incubation at 95 °C for 10 min in fragmentation buffer (Invitrogen). 100 ng of fragmented RNA were incubated in a 20 µL reaction system containing 2.5 µL glyoxal (Sigma) and 2.5 µL nitrite (Sigma) to induce selective deamination of unmethylated adenosine. RNA was purified by ethanol precipitation and RNA Clean & Concentrator kit (Zymo). Deamination efficiency was quantitatively assessed by LC‐MS/MS. Sequencing libraries were constructed from immunoprecipitated (IP) and input RNA samples using the NEBNext Ultra II Directional RNA Library Prep Kit (NEB), and sequenced on Illumina Hiseq X‐ten with paired‐end (PE) run and read lengths of 2 × 150 base pairs.
In Vitro Mutagenesis Assay
The full‐length coding sequence (CDS) of EcR and a ∼1.5 kb fragment flanking the target modification site in Cht10 were separately cloned into pAC5.1/ V5‐His b (pAc5.1b) vector using the EcoR V and Not I sites. Site mutations were gained by using a KOD‐Plus‐Mutagenesis Kit (TOYOBO) following the manufacturer's instructions. The primers used for the construction of recombinant plasmids are listed in Table S4 (Supporting Information).
S2 cells were cultured at 28 °C in a 24‐well plate for 24 h before transfection. The constructed plasmids were cotransfected with pAC5.1‐Mettl3 and pAC5.1‐eIF3‐S6 into the S2 cells by Lipofectamine 3000 reagent (Invitrogen). Cells were harvested 48 h post‐transfection and lysed in RIP buffer supplemented with RNase inhibitor. RNA‐protein complexes were immunoprecipitated using anti‐m⁶A (Abcam) or anti‐eIF3‐S6 (Genscript Biotech Corporation) antibodies. Co‐precipitated RNA was quantified by qPCR with normalization to β‐actin as an endogenous control.
Luciferase Reporter Assay
We amplified a ≈3.0‐kb genomic region upstream of the Mettl3 translation start site from the locust genomic DNA as the candidate promoter. This region was cloned into the pGL4.10 luciferase reporter vector (Promega). For normalization, the pGL4.73 vector, which contains the Renilla luciferase (hRluc) gene driven by the SV40 enhancer/promoter, was used as an internal control. S2 cells were co‐transfected with pGL4.10‐Mettl3 promoter construct, pGL4.73 reference plasmid, and Pac5.1b‐EcR plasmid after treatment with 20E or PBS (control) using Lipofectamine 3000 (Invitrogen). Luciferase activity was measured 48 h post‐transfection using the Dual‐Luciferase Reporter Assay System (Promega) on a GloMax 96 Microplate Luminometer. Data were presented as the ratio of firefly luciferase to Renilla luciferase activity.
Statistical Analysis
All data were analyzed using IBM SPSS statistics 19. The differences between treatments were compared using either Student's t‐test or one‐way analysis of variance (ANOVA) followed by Tukey's test for multiple comparisons. The differences of the survival curves were calculated using the Kaplan–Meier statistical analysis. All results were expressed as means ± SEM.
Conflict of Interest
The authors declare no conflict of interest.
Supporting information
Supporting Information
Acknowledgements
Z.H., Y.Z., and H.W. contributed equally to this work. The authors thank Professor Le Kang (Institute of Zoology, Chinese Academy of Sciences) for his helpful comments. This work was funded by the National Key Research and Development Program of China (No. 2022YFD1400500); the Natural Science Foundation of China (NSFC) (32372536, 32070505, 32302349, 32222072 and 32070484); the Support Project of High‐level Teachers in Beijing Municipal Universities in the Period of 14th Five–year Plan and the Natural Science Foundation of Beijing (6192021); the State Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences (Grant Nos. IPM2418).
Hu Z., Zhou Y., Wang H., et al. “Dynamic eIF3‐S6 Phase Separation Switch Instructed by m6A Modification Drives the Molting of Locusts.” Adv. Sci. 12, no. 39 (2025): e10505. 10.1002/advs.202510505
Contributor Information
Xiaojiao Guo, Email: guoxj@ioz.ac.cn.
Meiling Yang, Email: yangmeiling@cnu.edu.cn.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.;
References
- 1. Hesterlee S., Morton D. B., Curr. Biol. 1996, 6, 648. [DOI] [PubMed] [Google Scholar]
- 2. Xu T., Jiang X., Denton D., Kumar S., Cell Death Differ. 2020, 27, 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Suzuki R., Yaguchi H., Maekawa K., J. Insect Physiol. 2019, 117, 103892. [DOI] [PubMed] [Google Scholar]
- 4. Benrabaa S. A. M., Chang S. A., Chang E. S., Mykles D. L., Gen. Comp. Endocrinol. 2024, 355, 114548. [DOI] [PubMed] [Google Scholar]
- 5. Yang M., Wang Y., Jiang F., Song T., Wang H., Liu Q., Zhang J., Zhang J., Kang L., PLoS Genet. 2016, 12, 1006257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Zhang J., Liu X., Zhang J., Li D., Sun Y., Guo Y., Ma E., Zhu K. Y., Insect Biochem. Mol. Biol. 2010, 40, 824. [DOI] [PubMed] [Google Scholar]
- 7. Zhao X., Qin Z., Liu W., Liu X., Moussian B., Ma E., Li S., Zhang J., Insect Biochem. Mol. Biol. 2018, 92, 1. [DOI] [PubMed] [Google Scholar]
- 8. Liu X., Zhang Z., Zhang M., Zhao X., Zhang T., Liu W., Zhang J., Pestic. Biochem. Physiol. 2021, 178, 104945. [DOI] [PubMed] [Google Scholar]
- 9. Li D., Zhang J., Wang Y., Liu X., Ma E., Sun Y., Li S., Zhu K. Y., Zhang J., Insect Biochem. Mol. Biol. 2015, 58, 46. [DOI] [PubMed] [Google Scholar]
- 10. Sugahara R., Tanaka S., Shiotsuki T., Dev. Biol. 2017, 429, 71. [DOI] [PubMed] [Google Scholar]
- 11. Zhang Y., Li H., Lan Q., Liu X., Wu H., Zhang J., Zhao X., Wang Y., Genes (Basel) 2024, 15, 850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Song T. Q., Yang M. L., Wang Y. L., Liu Q., Wang H. M., Zhang J., Li T., Insect Sci. 2016, 23, 520. [DOI] [PubMed] [Google Scholar]
- 13. Liu X., Li F., Li D., Ma E., Zhang W., Zhu K. Y., Zhang J., PLoS One 2013, 8, 71970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Yu R., Liu W., Li D., Zhao X., Ding G., Zhang M., Ma E., Zhu K., Li S., Moussian B., Zhang J., J. Biol. Chem. 2016, 291, 24352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Holoch D., Moazed D., Nat. Rev. Genet. 2015, 16, 71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Yin H., Zhang X., Yang P., Zhang X., Peng Y., Li D.a, Yu Y., Wu Y.e, Wang Y., Zhang J., Ding X., Wang X., Yang A., Zhang R., Nat. Commun. 2021, 12, 1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. He L., Li H., Wu A., Peng Y., Shu G., Yin G., Mol. Cancer 2019, 18, 176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Qi Z., Zhang C., Jian H., Hou M., Lou Y., Kang Y.i, Wang W., Lv Y., Shang S., Wang C., Li X., Feng S., Zhou H., Cell Death Discov. 2023, 9, 159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Boo S. H., Kim Y. K., Exp. Mol. Med. 2020, 52, 400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Arguello A. E., Li A., Sun X., Eggert T. W., Mairhofer E., Kleiner R. E., Nat. Commun. 2022, 13, 4176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Orellana E. A., Liu Q.i, Yankova E., Pirouz M., De Braekeleer E., Zhang W., Lim J., Aspris D., Sendinc E., Garyfallos D. A., Gu M., Ali R., Gutierrez A., Mikutis S., Bernardes G. J. L., Fischer E. S., Bradley A., Vassiliou G. S., Slack F. J., Tzelepis K., Gregory R. I., Mol. Cell 2021, 81, 3323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. An Y., Duan H., Mol. Cancer 2022, 21, 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Sendinc E., Shi Y., Mol. Cell 2023, 83, 428. [DOI] [PubMed] [Google Scholar]
- 24. Roundtree I. A., Evans M. E., Pan T., He C., Cell 2017, 169, 1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Wang X., Lu Z., Gomez A., Hon G. C., Yue Y., Han D., Fu Y.e, Parisien M., Dai Q., Jia G., Ren B., Pan T., He C., Nature 2014, 505, 117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Wang T., Kong S., Tao M., Ju S., Mol. Cancer 2020, 19, 88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Wu Y., Zhang S., Yuan Q., Stem Cells Dev. 2016, 25, 1050. [DOI] [PubMed] [Google Scholar]
- 28. Xiao W., Adhikari S., Dahal U., Chen Y.u‐S., Hao Y.a‐J., Sun B.‐F.a, Sun H.‐Y., Li A., Ping X.‐L.i, Lai W.‐Y.i, Wang X., Ma H.‐L.i, Huang C.‐M., Yang Y., Huang N., Jiang G.‐B., Wang H.‐L., Zhou Q.i, Wang X.‐J., Zhao Y.‐L., Yang Y.‐G., Mol. Cell 2016, 61, 507. [DOI] [PubMed] [Google Scholar]
- 29. Liu L., Li H., Hu D., Wang Y., Shao W., Zhong J., Yang S., Liu J., Zhang J., Mol. Cancer 2022, 21, 32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Liu Z. Y., You Q. Y., Liu Z. Y., Lin L. C., Yang J. J., Tao H., Life Sci. 2024, 353, 122922. [DOI] [PubMed] [Google Scholar]
- 31. Qiu L., Jing Q., Li Y., Han J., Mol. Biomed. 2023, 4, 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Legrand C., Tuorto F., Hartmann M., Liebers R., Jacob D., Helm M., Lyko F., Genome Res. 2017, 27, 1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Fahrbach S. E., Smagghe G., Velarde R. A., Annu. Rev. Entomol. 2012, 57, 83. [DOI] [PubMed] [Google Scholar]
- 34. Henrich V. C., Brown N. E., Insect Biochem. Mol. Biol. 1995, 25, 881. [DOI] [PubMed] [Google Scholar]
- 35. Nagpure A., Choudhary B., Gupta R. K., Crit. Rev. Biotechnol. 2014, 34, 215. [DOI] [PubMed] [Google Scholar]
- 36. Chaudhari S. S., Arakane Y., Specht C. A., Moussian B., Boyle D. L., Park Y., Kramer K. J., Beeman R. W., Muthukrishnan S., Proc. Natl. Acad. Sci. USA 2011, 108, 17028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Man J., Zhang Q., Zhao T., Sun D., Sun W., Long K., Zhang Z., Biol. Trace Elem. Res. 2024, 202, 885. [DOI] [PubMed] [Google Scholar]
- 38. Cheng Y., Xie W., Pickering B. F., Chu K. L., Savino A. M., Yang X., Luo H., Nguyen D. T.t., Mo S., Barin E., Velleca A., Rohwetter T. M., Patel D. J., Jaffrey S. R., Kharas M. G., Cancer Cell 2021, 39, 958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Yang P., Mathieu C., Kolaitis R.‐M., Zhang P., Messing J., Yurtsever U., Yang Z., Wu J., Li Y., Pan Q., Yu J., Martin E. W., Mittag T., Kim H. J., Taylor J. P., Cell 2020, 181, 325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Yu J., Chai P., Xie M., Ge S., Ruan J., Fan X., Jia R., Genome Biol. 2021, 22, 85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Jiao Y., Palli S. R., Insect Biochem. Mol. Biol. 2023, 159, 103985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Zhang G., Xu Y., Wang X., Zhu Y., Wang L., Zhang W., Wang Y., Gao Y., Wu X., Cheng Y., Sun Q., Chen D., Nat. Commun. 2022, 13, 859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Wang M., Xiao Y.u, Li Y., Wang X., Qi S., Wang Y.e, Zhao L., Wang K., Peng W., Luo G.‐Z., Xue X., Jia G., Wu L., Cell Rep. 2021, 34, 108580. [DOI] [PubMed] [Google Scholar]
- 44. Guo Z., Bai Y., Zhang X., Guo L.e, Zhu L., Sun D., Sun K., Xu X., Yang X., Xie W., Wang S., Wu Q., Crickmore N., Zhou X., Zhang Y., Adv. Sci. (Weinh) 2024, 11, 2307650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Hinnebusch A. G., Trends Biochem. Sci. 2006, 31, 553. [DOI] [PubMed] [Google Scholar]
- 46. Hazra D., Chapat C., Graille M., Genes (Basel) 2019, 10, 49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Wilkinson E., Cui Y. H., He Y. Y., Front. Cell Dev. Biol. 2022, 10, 828683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Su Y., Maimaitiyiming Y., Wang L., Cheng X., Hsu C. H., Front. Cell Dev. Biol. 2021, 9, 786454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Jeon P., Ham H. J., Park S., Lee J. A., Cells 2022, 11, 2063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Lu Y., Gan L., Di S., Nie F., Shi H., Wang R., Yang F., Qin W., Wen W., Int. J. Biol. Macromol. 2024, 280, 135907. [DOI] [PubMed] [Google Scholar]
- 51. Maharana S., Wang J., Papadopoulos D. K., Richter D., Pozniakovsky A., Poser I., Bickle M., Rizk S., Guillén‐Boixet J., Franzmann T. M., Jahnel M., Marrone L., Chang Y.‐T., Sterneckert J., Tomancak P., Hyman A. A., Alberti S., Science 2018, 360, 918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Ries R. J., Zaccara S., Klein P., Olarerin‐George A., Namkoong S., Pickering B. F., Patil D. P., Kwak H., Lee J. H., Jaffrey S. R., Nature 2019, 571, 424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Zhang S., Zhao B. S., Zhou A., Lin K., Zheng S., Lu Z., Chen Y., Sulman E. P., Xie K., Bögler O., Majumder S., He C., Huang S., Cancer Cell 2017, 31, 591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Mathur L., Jung S., Jang C., Lee G., STAR Protoc. 2021, 2, 100724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Yang X., Wei X., Yang J., Du T., Yin C., Fu B., Huang M., Liang J. J., Gong P., Liu S., Xie W., Guo Z., Wang S., Wu Q., Nauen R., Zhou X., Bass C., Zhang Y., Sci. Adv. 2021, 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Yang M., Du B., Xu L., Wang H., Wang Y., Lin K., He G., Kang L., Proc. Natl. Acad. Sci. USA 2023, 120, 2215660120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Zhang H., Peng F., He C., Liu Y., Deng H., Fang X., Mol. Plant 2023, 16, 310. [DOI] [PubMed] [Google Scholar]
- 58. Liu C., Sun H., Yi Y., Shen W., Li K., Xiao Y.e, Li F., Li Y., Hou Y., Lu B.o, Liu W., Meng H., Peng J., Yi C., Wang J., Nat. Biotechnol. 2023, 41, 355. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.;
